Merck (MRK) and Schering-Plough (SGP) make two of the most widely sold drugs in the world. One is cholesterol drug Zetia. Another is a related drug called Vytorin. The sales of the treatments topped $5 billion last year.
Zetia and Vytorin are more examples of how little the FDA cares about the health of the general population.
The two drugs do not seem to be terribly effective. Worse, according to The New York Times, scientists are debating whether there is a link between the products and cancer.
A treatment that does little or nothing for the patient other than bring potential harm should not be on the market at all.
The FDA has become a fairly ineffective agency and that has been of benefit to many pharma companies. If Zetia were pulled from the market, Merck’s financials would be significantly damaged. Merck’s shares trade at just over $35, which is near a 52-week low. But, any investor buying in now faces the risk that the government will knuckle under to protests about Zetia and severely limit the drug’s use.
It is an odd brew. If patients using the Merck drug are helped by limits on Zetia’s prescriptions, Merck’s shareholders will be massacred.
Douglas A. McIntyre
The Average American Is Losing Momentum On Their Savings Every Day (Sponsor)
If you’re like many Americans and keep your money ‘safe’ in a checking or savings account, think again. The average yield on a savings account is a paltry .4%1 today. Checking accounts are even worse.
But there is good news. To win qualified customers, some accounts are paying more than 7x the national average. That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn a $200 bonus and up to 7X the national average with qualifying deposits. Terms apply. Member, FDIC.
Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.